Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Capital Leases (2018)

Zevra Therapeutics (ZVRA) has disclosed Capital Leases for 3 consecutive years, with $396000.0 as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Capital Leases changed N/A year-over-year to $396000.0, compared with a TTM value of $396000.0 through Dec 2018, changed N/A, and an annual FY2018 reading of $396000.0, changed N/A over the prior year.
  • Capital Leases was $396000.0 for Q4 2018 at Zevra Therapeutics, down from $451000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $515000.0 in Q1 2018 and bottomed at $3000.0 in Q3 2015.
  • Average Capital Leases over 3 years is $235750.0, with a median of $211000.0 recorded in 2014.